Cardinal Health, Inc. 

(Public, NYSE:CAH)   Watch this stock   
Find more results for CAH
Dec 7, 2009
Dublin Day
Nov 17, 2009
Lazard Capital Healthcare Conference - Webcast
Nov 5, 2009
Q1 2010 Earnings Conference Call - Webcast
Nov 5, 2009
Q1 2010 Earnings Release
Nov 4, 2009
Shareholders Meeting - Webcast
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2009
Net profit margin -0.25% 1.15%
Operating margin 0.81% 1.89%
EBITD margin - 2.29%
Return on average assets -1.09% 4.71%
Return on average equity -3.63% 13.88%
Employees 46,500 -

Address

7000 Cardinal Place
Dublin, OH 43017
United States - Map
+1-614-7575000 (Phone)
+1-614-7576000 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com
About Company - Wikipedia

Cardinal Health, Inc. discussed on blogs

Top Falling Stocks with Unusual Volume (1/6/2010) - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - 8 hours ago
Ranking U.S. Large Cap Stocks by Price Momentum as of 1/3/2010 ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Jan 4, 2010

Cardinal Health, Inc. discussions

  View all discussions »

Description

Cardinal Health, Inc. (Cardinal Health) is a provider of products and services to healthcare industry. During the fiscal year ended June 30, 2009 (fiscal 2009), the Company had three segments: Healthcare Supply Chain Services, Clinical and Medical Products and All Other. Effective July 1, 2009, the Company changed its segments to three segments: Pharmaceutical, Medical and CareFusion. On August 25, 2009, the Company spun-off 80.1% of a wholly owned subsidiary, CareFusion Corporation (CareFusion). Through its Healthcare Supply Chain Services-Pharmaceutical segment, the Company distributes a line of branded and generic pharmaceutical products, over-the-counter healthcare products and consumer products (pharmaceutical products). During fiscal 2009, the Company divested the Tecomet (orthopedic implants and instruments) and MedSystems (enteral devices and airway management products) businesses that were part of All Other segment.

Officers and directors

George S. Barrett
Chairman of the Board, Chief Executive Officer
Age: 54
Bio & Compensation - Reuters
Jeffrey W. Henderson
Chief Financial Officer
Age: 44
Bio & Compensation - Reuters
Stephen T. Falk
Executive Vice President, General Counsel, Secretary
Age: 44
Bio & Compensation - Reuters
Mark Blake
Executive Vice President - Strategy and Corporate Development
Age: 38
Bio & Compensation - Reuters
Craig S. Morford
Chief Legal and Compliance Officer
Age: 50
Bio & Compensation - Reuters
Carole S. Watkins
Chief Human Resources Officer
Age: 48
Bio & Compensation - Reuters
John F. Finn
Presiding Director
Age: 61
Bio & Compensation - Reuters
Richard C. Notebaert
Director
Age: 62
Bio & Compensation - Reuters
David W. Raisbeck
Director
Age: 60
Bio & Compensation - Reuters
Jean G. Spaulding M.D.
Director
Age: 61
Bio & Compensation - Reuters